Biomarkers in Monitoring for Efficacy of Immunotherapy and Chemoprevention of Bladder Cancer with Dimethylsulfoxide
Authors:
- JianYu RaoJRJianYu Rao
- Robert E. HurstRHRobert E. Hurst
- Rebecca B. BonnerRBRebecca B. Bonner
- John E. MellottJMJohn E. Mellott
- Gina M. RookerGRGina M. Rooker
- 1 February 1999
- journal article
- Published by Wiley in Cancer Detection Prevention
- Vol. 23 (2) , 163-171
Abstract
This study correlated biomarkers expressed in tumor and epithelial field with clinical response and recurrence. Of 25 bladder cancer patients, 11 received 6 weeks of intravesical Bacille Calmette-Guerin (BCG), and 14 were treated weekly with intravesical dimethylsulfoxide (DMSO) for 4 weeks to further modulate biomarker expression. G-actin, DNA aneuploidy, and p300 tumor antigen were evaluated by quantitative fluorescence image analysis on uroepithelial cells from bladder wash samples prior to and immediately following treatment. Excluding patients who did not respond to BCG (and who had persistently abnormal p300 and DNA markers), recurrence correlated with persistent abnormal G-actin findings. Of patients who were G-actin negative following therapy, only 25% recurred during follow-up in contrast to 67% in patients who were positive (p < 0.03 by Fisher's exact test). The odds ratio for recurrence was 6.00 (95% confidence interval: 1.3-28.6). Cytosolic G-actin levels can be an important intermediate end point marker for chemoprevention.Keywords
This publication has 22 references indexed in Scilit:
- Molecular Detection of Primary Bladder Cancer by Microsatellite AnalysisScience, 1996
- Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nucleiCytometry, 1994
- Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cellsCancer, 1993
- Activity of 4-HPR in superficial bladder caner using DNA flow cytometry as an intermediate endpointJournal of Cellular Biochemistry, 1992
- Cytokines in context.Journal of Cell Biology, 1991
- Quantitative Fluorescence Image Analysis in Bladder Cancer ScreeningJournal of Occupational and Environmental Medicine, 1990
- Current Understanding of Pathology of Bladder Cancer and Attendant ProblemsJournal of Occupational and Environmental Medicine, 1990
- Quantitative immunofluorescence, anti-ras p21 antibody specificity, and cellular oncoprotein levelsBiochemical and Biophysical Research Communications, 1990
- DNA hyperploidy as a marker for biological response to bladder carcinogen exposureInternational Journal of Cancer, 1988
- Dietary Carcinogens and AnticarcinogensScience, 1983